title: Down-regulation of Dicer in hepatocellular carcinoma.
abstract: Dicer, the key enzyme in the RNAi pathway, is misregulated in tumor tissues. The altered expression of Dicer is associated with clinical characteristics in patients with cancer. Liver carcinoma and adjacent non-neoplastic tissues were obtained from 36 patients with hepatocellular carcinoma (HCC) undergoing surgery. Expressions of Dicer mRNA were evaluated using the Real-time reverse transcription-PCR in 36 liver carcinoma tissues and 36 adjacent histologically non-cancerous liver tissues. Dicer mRNA levels were evaluated in relation to age, sex, tumor number, tumor size, tumor stage, and distant metastasis. Dicer mRNA level was significantly lower in malignant tissues than in the corresponding non-neoplastic tissues in 34 of the 36 patients with HCC (94.4%). The Dicer expression level was not associated with clinical characteristics, including age, sex, tumor number, tumor size, tumor stage, or distant metastasis in HCC cases. These results demonstrate that Dicer is significantly down-regulated in HCC, suggesting that reduced expression of Dicer may play an important role during the process of hepatocarcinogenesis.
authors.affiliation: Key Laboratory of Molecular Biology for Infectious Diseases of the State Ministry of Education, Institute for Viral Hepatitis, The Second Affiliated Hospital, Chongqing Medical University, 74# Linjiang Road, 400010, Chongqing, People's Republic of China.
authors.forename: Jin-Feng
authors.initials: JF
authors.lastname: Wu
authors.forename: Wei
authors.initials: W
authors.lastname: Shen
authors.forename: Nian-Zhou
authors.initials: NZ
authors.lastname: Liu
authors.forename: Gui-Li
authors.initials: GL
authors.lastname: Zeng
authors.forename: Mei
authors.initials: M
authors.lastname: Yang
authors.forename: Guo-Qing
authors.initials: GQ
authors.lastname: Zuo
authors.forename: Xiu-Ni
authors.initials: XN
authors.lastname: Gan
authors.forename: Hong
authors.initials: H
authors.lastname: Ren
authors.forename: Kai-Fu
authors.initials: KF
authors.lastname: Tang
mesh_terms: D000328:Adult; D000368:Aged; D015153:Blotting, Western; D006528:Carcinoma, Hepatocellular / Q000378:metabolism* / Q000473:pathology; D015536:Down-Regulation; D005260:Female; D006801:Humans; D008113:Liver Neoplasms / Q000378:metabolism* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D012333:RNA, Messenger / Q000032:analysis; D060888:Real-Time Polymerase Chain Reaction; D020133:Reverse Transcriptase Polymerase Chain Reaction; D043244:Ribonuclease III / Q000096:biosynthesis*
chemical_list: D012333:RNA, Messenger; D043244:Ribonuclease III
references.citation: Proc Natl Acad Sci U S A. 2004 Mar 2;101(9):2999-3004
references.pmid: 14973191
references.citation: Cancer Sci. 2005 Feb;96(2):111-5
references.pmid: 15723655
references.citation: J Gastroenterol Hepatol. 2006 Jan;21(1 Pt 1):15-21
references.pmid: 16706806
references.citation: Oncogene. 2008 Sep 25;27(43):5651-61
references.pmid: 18521080
references.citation: Gut. 2001 Jan;48(1):103-9
references.pmid: 11115830
references.citation: Gastroenterology. 2007 Aug;133(2):647-58
references.pmid: 17681183
references.citation: Int J Cancer. 2009 Jun 15;124(12):2855-63
references.pmid: 19347935
references.citation: Am J Pathol. 2006 Nov;169(5):1812-20
references.pmid: 17071602
references.citation: Cancer Res. 2008 Jul 1;68(13):5049-58
references.pmid: 18593903
references.citation: Nat Rev Cancer. 2006 Nov;6(11):857-66
references.pmid: 17060945
references.citation: Oncogene. 2002 Apr 11;21(16):2593-604
references.pmid: 11971194
references.citation: Leuk Res. 2009 Aug;33(8):e127
references.pmid: 19278725
references.citation: Proc Natl Acad Sci U S A. 2006 Jun 13;103(24):9136-41
references.pmid: 16754881
references.citation: J Exp Med. 2006 Oct 30;203(11):2519-27
references.pmid: 17060477
references.citation: J Clin Virol. 2005 Dec;34 Suppl 1:S1-3
references.pmid: 16461208
references.citation: N Engl J Med. 2008 Dec 18;359(25):2641-50
references.pmid: 19092150
references.citation: Mod Pathol. 2008 Jun;21(6):676-84
references.pmid: 18327211
references.citation: Ann Surg. 1999 Jun;229(6):790-9; discussion 799-800
references.pmid: 10363892
references.citation: Nat Rev Cancer. 2006 Apr;6(4):259-69
references.pmid: 16557279
references.citation: Curr Opin Gen Surg. 1993;:257-64
references.pmid: 7583984
references.citation: Oncogene. 2006 Apr 20;25(17):2537-45
references.pmid: 16331254
references.citation: Hepatology. 2008 Apr;47(4):1223-32
references.pmid: 18307259
references.citation: Cancer Res. 2007 Mar 1;67(5):2345-50
references.pmid: 17332367
references.citation: Cancer Res. 2007 Jul 1;67(13):6092-9
references.pmid: 17616664
references.citation: Hepatology. 2008 Jun;47(6):1955-63
references.pmid: 18433021
references.citation: Gastroenterology. 2008 Jul;135(1):257-69
references.pmid: 18555017
references.citation: Gastroenterology. 2009 Jun;136(7):2304-2315.e1-4
references.pmid: 19272382
references.citation: Hepatology. 2009 Apr;49(4):1194-202
references.pmid: 19133651
references.citation: Int J Cancer. 2008 Oct 1;123(7):1616-22
references.pmid: 18649363